Solid tumour panel delivers consistent, reliable results

Fully validated on formalin-fixed, paraffin-embedded (FFPE) samples, a new 60-gene next generation sequencing (NGS) hybridization-based enrichment panel offers researchers accurate and reliable solid tumour profiling for both known and novel variants. The SureSeq Solid Tumour Panel covers key genes for a range of cancer types including breast, prostate, ovarian, lung and colorectal. All exons of these genes are fully covered, including mutation hotspots, enabling both detection and discovery of known and novel variants respectively. The panel minimizes PCR bias and duplications commonly associated with alternative enrichment methodologies, enabling greater run-to-run consistency. Oxford Gene Technology